Scholarlink

Background <p>Osteosarcopenia, defined as the co-existence of osteopenia/osteoporosis and sarcopenia, may influence frailty risk in older adults. However, the longitudinal association between osteosarcopenia or its components and frailty remain unclear. This study aimed to address this.</p> Methods <p>Data from a prospective cohort study of community-dwelling adults in Australia. Frailty was defined by the presence of ≥ 3 components based on Fried criteria: exhaustion, slow gait speed, low grip strength, unintentional weight loss, and low physical activity. Osteosarcopenia was defined by osteopenia/osteoporosis (WHO criteria) and sarcopenia (European Working Group on Sarcopenia in Older People [EWGSOP2] and Sarcopenia Definition and Outcome consortium [SDOC]). Multivariable logistic regression models evaluated the associations between osteosarcopenia, its components and frailty.</p> Results <p>Of 300 enrolled, 151 (mean age: 65.1years, 59.6%women) completed follow-up (median: 4.8 years). Among 143 non-frails at baseline, 13 (9.1%) transitioned to frailty. Osteosarcopenia (versus non-osteosarcopenia) was associated with frailty irrespective of the definition used: EWGSOP2: OR = 9.53, 95%CI 2.53–35.92; SDOC: OR = 9.19, 95%CI 2.19–38.56). Grip strength reduction by 1&#xa0;kg (OR = 0.92, 95%CI 0.84–1.00) and gait speed reduction by 0.1&#xa0;m/sec (OR = 0.67, 95%CI 0.53–0.85) were associated with 8% and 33% lower odds of frailty, respectively, whereas bone mineral density or lean mass was not. An interaction between bone-muscle function and frailty risk was observed (<i>p</i> &lt; 0.011), whereby higher values of grip strength were associated with lower odds of frailty when bone density was lower.</p> Conclusion <p>In this prospective cohort study, osteosarcopenia increased the risk of frailty. Our interaction analysis suggests therapies targeting bone density and grip strength may mitigate frailty.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Osteosarcopenia, bone-muscle interactions, and frailty risk: A prospective cohort study of community-dwelling older adults

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月10日

查看全文
  • Mizhgan Fatima,
  • Ben Kirk,
  • Sara Vogrin,
  • Jason Talevski,
  • Sharon Brennan-Olsen,
  • Gustavo Duque

摘要

Background

Osteosarcopenia, defined as the co-existence of osteopenia/osteoporosis and sarcopenia, may influence frailty risk in older adults. However, the longitudinal association between osteosarcopenia or its components and frailty remain unclear. This study aimed to address this.

Methods

Data from a prospective cohort study of community-dwelling adults in Australia. Frailty was defined by the presence of ≥ 3 components based on Fried criteria: exhaustion, slow gait speed, low grip strength, unintentional weight loss, and low physical activity. Osteosarcopenia was defined by osteopenia/osteoporosis (WHO criteria) and sarcopenia (European Working Group on Sarcopenia in Older People [EWGSOP2] and Sarcopenia Definition and Outcome consortium [SDOC]). Multivariable logistic regression models evaluated the associations between osteosarcopenia, its components and frailty.

Results

Of 300 enrolled, 151 (mean age: 65.1years, 59.6%women) completed follow-up (median: 4.8 years). Among 143 non-frails at baseline, 13 (9.1%) transitioned to frailty. Osteosarcopenia (versus non-osteosarcopenia) was associated with frailty irrespective of the definition used: EWGSOP2: OR = 9.53, 95%CI 2.53–35.92; SDOC: OR = 9.19, 95%CI 2.19–38.56). Grip strength reduction by 1 kg (OR = 0.92, 95%CI 0.84–1.00) and gait speed reduction by 0.1 m/sec (OR = 0.67, 95%CI 0.53–0.85) were associated with 8% and 33% lower odds of frailty, respectively, whereas bone mineral density or lean mass was not. An interaction between bone-muscle function and frailty risk was observed (p < 0.011), whereby higher values of grip strength were associated with lower odds of frailty when bone density was lower.

Conclusion

In this prospective cohort study, osteosarcopenia increased the risk of frailty. Our interaction analysis suggests therapies targeting bone density and grip strength may mitigate frailty.